Share your opinion and earn yourself a free Motley Fool premium report!

We are looking for Fools to join a 75 minute online independent market research forum on 15th / 16th December.

To find out more and express your interest please click here

Will AstraZeneca plc, Shanks Group plc And Sports Direct International Plc Make Storming Comebacks?

Are these 3 stocks worthy of ‘turnaround’ status? AstraZeneca plc (LON: AZN), Shanks Group plc (LON: SKS) and Sports Direct International Plc (LON: SPD).

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Shares in waste disposal company Shanks (LSE: SKS) have fallen by 4% today after it released a profit warning. Its update stated that market conditions in the oil, gas and electricity sectors have been challenging and this means that it now expects to miss forecasts for the full year. It also separately announced the sale of a non-core asset for £30m.

Despite the difficult trading conditions, Shanks’ commercial division has continued to deliver strong profit growth, driven by the company’s self-help initiatives. And its hazardous waste division has also traded robustly despite the deterioration in the oil and gas sector, which makes up around half of its sales. But with Shanks’ municipal division delivering worse performance than expected, its near-term outlook remains very challenging.

Looking ahead, Shanks was expected to post a fall in earnings of 5% prior to today’s update. As such, investor sentiment could worsen in the near term as the market begins to price-in an additional deterioration in its profit outlook. And even though Shanks is expected to rebound with double-digit earnings growth next year, its price-to-earnings (P/E) ratio of 17.7 indicates that its risk/reward ratio is relatively unfavourable at the present time.

Turnaround stock?

Also recording a falling share price today is Sports Direct (LSE: SPD), with its shares having declined by almost 30% since the turn of the year due in part to its own profit warning. This was at least partly because of challenging performance in its European division and while disappointing, international expansion could still offer improved growth prospects for the company in the long run.

Clearly, Sports Direct is often in the news regarding its staffing policies, but it remains one of the most successful British retailers of recent years. Its business model was able to adapt to the cost of living crisis during the Credit Crunch and now needs to adapt to a UK consumer who has higher disposable income in real terms.

This could be a challenge and the company’s share price may come under pressure in the short run as its dirt cheap pricing could hold less appeal with wage growth being higher than inflation. But Sports Direct’s price-to-earnings growth (PEG) ratio of 1 indicates that it could become a top notch turnaround stock.

Better times ahead?

Similarly, AstraZeneca (LSE: AZN) is also enduring a very challenging period at the present time, with the pharmaceutical company being forced to come to terms with a patent cliff that has caused a severe decline in its earnings in recent years. Looking ahead, this is set to continue, with AstraZeneca expected to report a fall in its bottom line of 6% in the current year.

However, while this is disappointing, the market appears to be looking further out to AstraZeneca’s expected turnaround. With its pipeline gaining momentum through multiple acquisitions and drug development/approval news being relatively encouraging (as recent news has shown), investor sentiment could improve and push the company’s share price higher after its decline of 4% in the last year. And with AstraZeneca trading on a P/E ratio of 15.9, it continues to offer excellent turnaround potential.

Peter Stephens owns shares of AstraZeneca. The Motley Fool UK has recommended AstraZeneca and Sports Direct International. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Young mixed-race couple sat on the beach looking out over the sea
Investing Articles

Investing in high-yield dividend stocks isn’t the only way to compound returns in an ISA or SIPP and build wealth

Generous payouts from dividend stocks can be appealing. But another strategy can offer higher returns over the long run, says…

Read more »

Middle-aged white man wearing glasses, staring into space over the top of his laptop in a coffee shop
Investing Articles

A rare buying opportunity for a defensive FTSE 100 company?

A FTSE 100 stock just fell 5% in a day without anything changing in the underlying business. Is this the…

Read more »

Two elderly people relaxing in the summer sunshine Box Hill near Dorking Surrey England
Investing Articles

Simplify your investing life with this one key tip from Warren Buffett

Making moves in the stock market can be complicated. But as Warren Buffett points out, if you don’t want it…

Read more »

Tesco employee helping female customer
Investing Articles

Is Tesco a second income gem after its 12.9% dividend boost?

As a shareholder, our writer was happy to see Tesco raise dividends -- again. Is it finally a serious contender…

Read more »

Rolls-Royce Hydrogen Test Rig at Loughborough University
Investing Articles

Has the Rolls-Royce share price gone too far?

Stephen Wright breaks out the valuation models to see whether the Rolls-Royce share price might still be a bargain, even…

Read more »

Tŵr Mawr lighthouse (meaning "great tower" in Welsh), on Ynys Llanddwyn on Anglesey, Wales, marks the western entrance to the Menai Strait.
Investing Articles

How much do you need to invest in a FTSE 100 ETF for £1,000 monthly passive income?

Andrew Mackie tested whether a FTSE 100 ETF portfolio could deliver £1,000 a month in passive income – the results…

Read more »

Two business people sitting at cafe working on new project using laptop. Young businesswoman taking notes and businessman working on laptop computer.
Investing Articles

One of my top passive income stocks to consider for 2026 is…

This under-the-radar income stock has grown its dividend by over 370% in the last five years! And it might just…

Read more »

Two female adult friends walking through the city streets at Christmas. They are talking and smiling as they do some Christmas shopping.
Investing Articles

Here’s how you can invest £5,000 in UK stocks to start earning a second income in 2026

Zaven Boyrazian looks at some of the top-performing UK stocks in 2025, and shares which dividend-paying sector he thinks could…

Read more »